The pharmaceutical company Almirall, a member of CATALONIA.HEALTH, announced at the JPMorgan HealthCare 2025 Conference, an update of its strategy and business perspectives.

Medical technology company Vitalera, a member of CATALONIA.HEALTH, achieved a significant milestone by successfully completing the rigorous re-classification process to MDR Class IIa certification.

The venture capital company Invivo Partners, a member of CATALONIA.HEALTH, announced the closing of a €20 million Series A financing round for the biotechnology company Neumirna Therapeutics.

The call for the eleventh edition of the CATALONIA.HEALTH Award is now open. Previously known as Bioèxit Award, the recognition joins the change of the association's brand and adapts the name to include all sector actors.

From CATALONIA.HEALTH we wish you a happy 2025, very especially to the more than 240 members, as well as to the companies and collaborating organisations and health professionals who have accompanied us during this year. We hope you continue with us in 2025!

Ysios Capital, gestora de capital risc especialitzada en el sector biotecnològic i membre de CATALONIA.HEALTH, i Andbank Wealth Management, gestora de fons del banc privat Andbank, han anunciat la nova aliança. A través d’aquesta unió llancen el Telescope Biotech Fund, un fons amb vocació global que inverteix en companyies cotitzades del sector biomèdic, principalment a Nasdaq i NYSE.

The biomedical consulting firm GENESIS Biomed, member of CATALONIA.HEALTH, will close in 2024 with an accumulated turnover of 9 million euros since the start of its activity in 2017. In addition, it has developed a total of 385 projects for 220 clients. 

The Digital Catalonia Alliance (DCA) has held a new edition of matchmaking, the DCA's service for generating connections between alliance members and organisations seeking new technological solutions. This last edition of the event once again counted on the collaboration of CATALONIA.HEALTH, as well as the Fundació Tic Salut Social, in order to boost the participation of the health sector and to detect new challenges and facilitate connections with DCA companies.

The medical diagnostics company Deepull, member of CATALONIA.HEALTH, announced that they have received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its UllCORE Bloodstream Infection (BSI) Test. 

The main public hospitals and institutions specialized in Alzheimer's research in the city of Barcelona, including the Hospital de Sant Pau, the Hospital Clínic de Barcelona, the Hospital del Mar and the Barcelonaβeta Brain Research Center (BBRC), all members of CATALONIA.HEALTH, have created the Barcelona Alzheimer's HUB.